Skip to content

Clinical trials

Mesothelioma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Country / region: France Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20121
20132
20152
20168
20171
20181
20192
20201
20212
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie2
Bayer2
Epizyme, Inc.2
Intergroupe Francophone de Cancerologie Thoracique2
Tango Therapeutics, Inc.2
Amphera BV1
AstraZeneca1
Boehringer Ingelheim1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma28
Carcinoma, Non-Small-Cell Lung6
Melanoma5
Neoplasms5
Carcinoma, Hepatocellular4
Carcinoma, Merkel Cell4
Cholangiocarcinoma4
Mesothelioma, Malignant4
Ovarian Neoplasms4
Small Cell Lung Carcinoma4

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.